211 related articles for article (PubMed ID: 38724493)
1. Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis.
Rosenberger G; Li W; Turunen M; He J; Subramaniam PS; Pampou S; Griffin AT; Karan C; Kerwin P; Murray D; Honig B; Liu Y; Califano A
Nat Commun; 2024 May; 15(1):3909. PubMed ID: 38724493
[TBL] [Abstract][Full Text] [Related]
2. Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis.
Rosenberger G; Li W; Turunen M; He J; Subramaniam PS; Pampou S; Griffin AT; Karan C; Kerwin P; Murray D; Honig B; Liu Y; Califano A
bioRxiv; 2023 Feb; ():. PubMed ID: 36824919
[TBL] [Abstract][Full Text] [Related]
3. Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target.
Jung JH; You S; Oh JW; Yoon J; Yeon A; Shahid M; Cho E; Sairam V; Park TD; Kim KP; Kim J
Cancer Lett; 2018 Nov; 437():1-12. PubMed ID: 30145203
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance.
Zhang X; Maity TK; Ross KE; Qi Y; Cultraro CM; Bahta M; Pitts S; Keswani M; Gao S; Nguyen KDP; Cowart J; Kirkali F; Wu C; Guha U
Cancer Res; 2021 Jun; 81(11):3051-3066. PubMed ID: 33727228
[TBL] [Abstract][Full Text] [Related]
5. Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells.
Ali NA; Molloy MP
Proteomics; 2011 Aug; 11(16):3390-401. PubMed ID: 21751366
[TBL] [Abstract][Full Text] [Related]
6. Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab.
Abe Y; Nagano M; Kuga T; Tada A; Isoyama J; Adachi J; Tomonaga T
Sci Rep; 2017 Sep; 7(1):10463. PubMed ID: 28874695
[TBL] [Abstract][Full Text] [Related]
7. Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK.
Kubiniok P; Lavoie H; Therrien M; Thibault P
Mol Cell Proteomics; 2017 Apr; 16(4):663-679. PubMed ID: 28188228
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of multiple protein kinase activities associated with secondary imatinib resistance in gastrointestinal stromal tumors as revealed by quantitative phosphoproteome analysis.
Nagata K; Kawakami T; Kurata Y; Kimura Y; Suzuki Y; Nagata T; Sakuma Y; Miyagi Y; Hirano H
J Proteomics; 2015 Feb; 115():132-42. PubMed ID: 25554490
[TBL] [Abstract][Full Text] [Related]
9. Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells.
Chang Y; Park KH; Lee JE; Han KC
Biochem Biophys Res Commun; 2018 Oct; 505(1):187-193. PubMed ID: 30243723
[TBL] [Abstract][Full Text] [Related]
10. Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer.
Oyama M; Nagashima T; Suzuki T; Kozuka-Hata H; Yumoto N; Shiraishi Y; Ikeda K; Kuroki Y; Gotoh N; Ishida T; Inoue S; Kitano H; Okada-Hatakeyama M
J Biol Chem; 2011 Jan; 286(1):818-29. PubMed ID: 21044952
[TBL] [Abstract][Full Text] [Related]
11. Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in
Stewart A; Coker EA; Pölsterl S; Georgiou A; Minchom AR; Carreira S; Cunningham D; O'Brien ME; Raynaud FI; de Bono JS; Al-Lazikani B; Banerji U
Mol Cancer Ther; 2019 Aug; 18(8):1396-1404. PubMed ID: 31262731
[TBL] [Abstract][Full Text] [Related]
12. Integrating proteomic and phosphoproteomic data for pathway analysis in breast cancer.
Ren J; Wang B; Li J
BMC Syst Biol; 2018 Dec; 12(Suppl 8):130. PubMed ID: 30577793
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling.
Lescarbeau RM; Kaplan DL
BMC Cancer; 2014 May; 14():325. PubMed ID: 24885093
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.
Wu X; Zahari MS; Renuse S; Nirujogi RS; Kim MS; Manda SS; Stearns V; Gabrielson E; Sukumar S; Pandey A
Mol Cell Proteomics; 2015 Nov; 14(11):2887-900. PubMed ID: 26330541
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer.
Yoshida T; Zhang G; Smith MA; Lopez AS; Bai Y; Li J; Fang B; Koomen J; Rawal B; Fisher KJ; Chen YA; Kitano M; Morita Y; Yamaguchi H; Shibata K; Okabe T; Okamoto I; Nakagawa K; Haura EB
Clin Cancer Res; 2014 Aug; 20(15):4059-4074. PubMed ID: 24919575
[TBL] [Abstract][Full Text] [Related]
16. Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance.
Alcolea MP; Casado P; Rodríguez-Prados JC; Vanhaesebroeck B; Cutillas PR
Mol Cell Proteomics; 2012 Aug; 11(8):453-66. PubMed ID: 22547687
[TBL] [Abstract][Full Text] [Related]
17. Phosphoproteomic Analysis Identifies Signaling Pathways Regulated by Curcumin in Human Colon Cancer Cells.
Sato T; Higuchi Y; Shibagaki Y; Hattori S
Anticancer Res; 2017 Sep; 37(9):4789-4798. PubMed ID: 28870897
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line.
Lee YY; Kim HP; Kang MJ; Cho BK; Han SW; Kim TY; Yi EC
Exp Mol Med; 2013 Nov; 45(11):e64. PubMed ID: 24263233
[TBL] [Abstract][Full Text] [Related]
19. Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells.
Alli-Shaik A; Wee S; Lim LHK; Gunaratne J
Breast Cancer Res; 2017 Dec; 19(1):132. PubMed ID: 29233185
[TBL] [Abstract][Full Text] [Related]
20. Systemic analysis of tyrosine kinase signaling reveals a common adaptive response program in a HER2-positive breast cancer.
Schwill M; Tamaskovic R; Gajadhar AS; Kast F; White FM; Plückthun A
Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
